PD-L1: An unavoidable biomarker in advanced triple-negative breast cancer

Mira Akiki, Fady Gh Haddad, Hampig Raphael Kourie, Abir Khaddage, Viviane Track Smayra

Research output: Contribution to journalReview articlepeer-review

8 Scopus citations
Original languageEnglish (US)
Pages (from-to)1539-1541
Number of pages3
JournalBiomarkers in Medicine
Volume13
Issue number18
DOIs
StatePublished - 2019
Externally publishedYes

Keywords

  • breast cancer
  • clinical trials
  • immunotherapy
  • oncology
  • PD-L1
  • TNBC
  • triple negative

ASJC Scopus subject areas

  • Drug Discovery
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this